ABUS vs RL
Arbutus Biopharma Corp (ABUS) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported RL revenue for 2025-03-29 was $7.08B. Net income was $742.9M. Revenue was up 6.7% from 2024-03-30 to 2025-03-29. RL currently screens at market cap $16.95B and trailing P/E 24.1.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the ABUS and RL stock pages for the full models.
Not investment advice.